Prophylaxis with defibrotide prevents veno-occlusieve disease in stem cell tranplantation after gemtuzumab ozogamicin exposure.

A.B. Versluijs; R. Bhattacharaya; C. Steward; J. Cornish; A. Oakhill; N. Goulden

Prophylaxis with defibrotide prevents veno-occlusieve disease in stem cell tranplantation after gemtuzumab ozogamicin exposure.

Translated title of the contribution: Prophylaxis with defibrotide prevents veno-occlusieve disease in stem cell tranplantation after gemtuzumab ozogamicin exposure.

A.B. Versluijs, R. Bhattacharaya, C. Steward, J. Cornish, A. Oakhill, N. Goulden

Research output: Contribution to journal › Article › Academic

Translated title of the contribution	Prophylaxis with defibrotide prevents veno-occlusieve disease in stem cell tranplantation after gemtuzumab ozogamicin exposure.
Original language	Undefined/Unknown
Pages (from-to)	1968
Number of pages	1
Journal	Blood
Volume	2004
Issue number	103
Publication status	Published - 2004

Cite this

@article{9105e2967e46432e89ec2f7275d9458d,

title = "Prophylaxis with defibrotide prevents veno-occlusieve disease in stem cell tranplantation after gemtuzumab ozogamicin exposure.",

author = "A.B. Versluijs and R. Bhattacharaya and C. Steward and J. Cornish and A. Oakhill and N. Goulden",

year = "2004",

language = "Undefined/Unknown",

volume = "2004",

pages = "1968",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier",

number = "103",

}